Group One Trading
DNTH icon

Group One Trading’s Dianthus Therapeutics DNTH Stock Holding History

Group One Trading’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
2,500
-300
-11% -$17.4K ﹤0.01% 4075
2025
Q4 		$115K Sell
2,800
-42,800
-94% -$1.66M ﹤0.01% 4876
2025
Q3 		$1.79M Buy
45,600
+20,900
+85% +$534K ﹤0.01% 2425
2025
Q2 		$460K Buy
+24,700
New +$463K ﹤0.01% 3501
2021
Q3 		– Sell
-6
Closed -$1K – 8286
2021
Q2 		$1K Sell
6
-2,188
-100% -$402K ﹤0.01% 8002
2021
Q1 		$416K Buy
2,194
+1,825
+495% +$307K ﹤0.01% 4255
2020
Q4 		$46K Buy
369
+344
+1,376% +$39K ﹤0.01% 5053
2020
Q3 		$3K Sell
25
-6
-19% -$711 ﹤0.01% 5738
2020
Q2 		$4K Buy
31
+25
+417% +$3.52K ﹤0.01% 5413
2020
Q1 		$1K Hold
6
– – ﹤0.01% 5065
2019
Q4 		$2K Buy
+6
New +$1.12K ﹤0.01% 4888

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Group One Trading's DNTH Position: Q1 2026 in Review

Group One Trading increased its Dianthus Therapeutics (DNTH) stake by 315% in Q1 2026, buying an estimated $152K and bringing the position to 3,453 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

Group One Trading first reported a position in DNTH in Q4 2019 and has held it in 6 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Group One Trading held 3,453 shares of Dianthus Therapeutics worth $290K as of Q1 2026.
  • Group One Trading bought 2,621 Dianthus Therapeutics shares in Q1 2026, an estimated $152K.
  • Dianthus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3823 holding.
  • Group One Trading first reported a position in Dianthus Therapeutics in Q4 2019 and has held it in 6 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.